The risk of recurrence in breast cancer patients treated with tamoxifen: Polymorphisms of CYP2D6 and ABCB1

The risk of recurrence in breast cancer patients treated with tamoxifen: Polymorphisms of CYP2D6 and ABCB1

CYP2D6 plays a major role in the metabolism of tamoxifen, and polymorphism of P-glycoprotein has been associated with resistance of many drug therapies. This study investigates the clinical impact of genetic variants of CYP2D6 and ABCB1 in breast cancer patients treated with tamoxifen. Blood samples...

Full description

Bibliographic Details
Published in:AAPS Journal
Main Author: Teh L.K.; Mohamed N.I.; Salleh M.Z.; Rohaizak M.; Shahrun N.S.; Saladina J.J.; Shia J.K.S.; Roslan H.; Sood S.; Rajoo T.S.; Muniandy S.P.; Henry G.; Ngow H.A.; Hla U K.T.; Din J.
Format: Article
Language:English
Published: 2012
Online Access:https://www.scopus.com/inward/record.uri?eid=2-s2.0-84857627005&doi=10.1208%2fs12248-011-9313-6&partnerID=40&md5=eea28b3b2f6906aaed8c5112ae07b2b9

Internet

https://www.scopus.com/inward/record.uri?eid=2-s2.0-84857627005&doi=10.1208%2fs12248-011-9313-6&partnerID=40&md5=eea28b3b2f6906aaed8c5112ae07b2b9

Similar Items